During the past decade, Red Star Research, LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Red Star Research, LLC" are "Migraine" (7 trials), "Migraine, With or Without Aura" (5 trials), "Acute Migraine" (1 trials), "Pediatric Migraine" (1 trials) and "Temporomandibular Disorders (TMD)" (1 trials). Many other conditions were trialed in "Red Star Research, LLC" in a lesser frequency.

Most popular intervention types in "Red Star Research, LLC" are "Drug" (15 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Rimegepant" (8 trials), "Placebo-matching Ubrogepant" (2 trials), "Ubrogepant" (2 trials) and "Zavegepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Red Star Research, LLC" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Red Star Research, LLC". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Red Star Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Red Star Research, LLC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".